The Apheresis Devices Market is being driven by Growth in new indications for plasma products
The Apheresis Devices Market is expected to grow at a CAGR of 8.45% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1.59 billion. The global apheresis devices market is experiencing noteworthy advancements, with a focus on the development of more sophisticated and efficacious apheresis devices due to technological innovations. These technological breakthroughs are enhancing the accuracy, safety, and user-friendliness of apheresis procedures, leading to improved patient outcomes. Notable developments include Terumo Blood and Cell Technologies' collaboration with Eliaz Therapeutics in July 2022 to research and commercialize a novel therapeutic apheresis treatment for acute kidney injury (AKI). Additionally, in June 2022, the UK's National Health Service (NHS) England selected Terumo Blood and Cell Technologies' Spectra Optia Apheresis System for automated red blood cell exchange (RBCX) to address sickle cell disease under the NHS MedTech Funding Mandate (MTFM).
Get more information on Apheresis Devices Market by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Product (Systems, Consumables) Application (Neurological disorders, Haematological disorders, Renal disorders, Autoimmune disorders) Geography (North America, Europe, Asia, Rest of World (ROW)).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Apheresis Devices Market Research Report
Find out which segment is leading the market by accessing the free PDF report
Apheresis is a medical process used to separate components from whole blood for therapeutic purposes. Apheresis devices are utilized in treating various blood-related disorders such as leukemia, lymphoma, myeloma, autoimmune diseases, and cancer. Portable apheresis devices enable plasma therapy, RBC unit collection, and apheresis kits for blood donors. Apheresis equipment includes centrifugation and membrane separation equipment. Membrane filtration is used for separating platelets and white blood cells. Apheresis is employed in clinical settings for vaccines, drugs, and convalescent plasma therapy. Blood components are used for therapeutic purposes, including cancer treatments.
The Apheresis Devices Market is a significant segment of the global healthcare equipment industry, estimated to be worth USD39.56 billion in 2023, according to Technavio's market research. Apheresis devices are utilized in the treatment of various blood-related disorders, such as leukemia, lymphoma, and myeloma, as well as in blood transfusions. These portable, advanced devices enable the selective separation and collection of specific components from the blood, enhancing patient care and treatment efficacy. The global healthcare equipment market, encompassing manufacturers of diagnostic equipment, devices, implants, accessories, and consumables, generated a combined revenue of USD395.63 billion in 2023.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
